BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hoekstra R, Nibourg GA, van der Hoeven TV, Ackermans MT, Hakvoort TB, van Gulik TM, Lamers WH, Elferink RP, Chamuleau RA. The HepaRG cell line is suitable for bioartificial liver application. Int J Biochem Cell Biol. 2011;43:1483-1489. [PMID: 21726661 DOI: 10.1016/j.biocel.2011.06.011] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Herzog N, Hansen M, Miethbauer S, Schmidtke KU, Anderer U, Lupp A, Sperling S, Seehofer D, Damm G, Scheibner K, Küpper JH. Primary-like human hepatocytes genetically engineered to obtain proliferation competence display hepatic differentiation characteristics in monolayer and organotypical spheroid cultures. Cell Biol Int 2016;40:341-53. [PMID: 26715207 DOI: 10.1002/cbin.10574] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
2 van der Mark VA, Rudi de Waart D, Shevchenko V, Elferink RP, Chamuleau RA, Hoekstra R. Stable Overexpression of the Constitutive Androstane Receptor Reduces the Requirement for Culture with Dimethyl Sulfoxide for High Drug Metabolism in HepaRG Cells. Drug Metab Dispos 2017;45:56-67. [PMID: 27780834 DOI: 10.1124/dmd.116.072603] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
3 Nibourg GA, Hoekstra R, van der Hoeven TV, Ackermans MT, Hakvoort TB, van Gulik TM, Chamuleau RA. Increased hepatic functionality of the human hepatoma cell line HepaRG cultured in the AMC bioreactor. Int J Biochem Cell Biol 2013;45:1860-8. [PMID: 23770120 DOI: 10.1016/j.biocel.2013.05.038] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
4 Wagner A, Röhrs V, Materne EM, Hiller T, Kedzierski R, Fechner H, Lauster R, Kurreck J. Use of a three-dimensional humanized liver model for the study of viral gene vectors. J Biotechnol 2015;212:134-43. [PMID: 26356676 DOI: 10.1016/j.jbiotec.2015.08.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
5 Jang M, Kleber A, Ruckelshausen T, Betzholz R, Manz A. Differentiation of the human liver progenitor cell line (HepaRG) on a microfluidic-based biochip. J Tissue Eng Regen Med 2019;13:482-94. [PMID: 30746894 DOI: 10.1002/term.2802] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
6 Adam AAA, van der Mark VA, Ruiter JPN, Wanders RJA, Oude Elferink RPJ, Chamuleau RAFM, Hoekstra R. Overexpression of carbamoyl-phosphate synthase 1 significantly improves ureagenesis of human liver HepaRG cells only when cultured under shaking conditions. Mitochondrion 2019;47:298-308. [PMID: 30802674 DOI: 10.1016/j.mito.2019.02.005] [Reference Citation Analysis]
7 Atzrodt J, Derdau V, Kerr WJ, Reid M. Deuterium- und tritiummarkierte Verbindungen: Anwendungen in den modernen Biowissenschaften. Angew Chem 2018;130:1774-802. [DOI: 10.1002/ange.201704146] [Cited by in Crossref: 69] [Cited by in F6Publishing: 31] [Article Influence: 17.3] [Reference Citation Analysis]
8 Kang HE, Malinen MM, Saran C, Honkakoski P, Brouwer KLR. Optimization of Canalicular ABC Transporter Function in HuH-7 Cells by Modification of Culture Conditions. Drug Metab Dispos 2019;47:1222-30. [PMID: 31371422 DOI: 10.1124/dmd.119.087676] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Pasqua M, Pereira U, Messina A, de Lartigue C, Vigneron P, Dubart-Kupperschmitt A, Legallais C. HepaRG Self-Assembled Spheroids in Alginate Beads Meet the Clinical Needs for Bioartificial Liver. Tissue Eng Part A 2020;26:613-22. [PMID: 31914890 DOI: 10.1089/ten.TEA.2019.0262] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 You L, Zhang B, Tang YJ. Application of stable isotope-assisted metabolomics for cell metabolism studies. Metabolites 2014;4:142-65. [PMID: 24957020 DOI: 10.3390/metabo4020142] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
11 Huang D, Gibeley SB, Xu C, Xiao Y, Celik O, Ginsberg HN, Leong KW. Engineering liver microtissues for disease modeling and regenerative medicine. Adv Funct Mater 2020;30:1909553. [PMID: 33390875 DOI: 10.1002/adfm.201909553] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
12 Moedas M, Adam A, Farelo M, Ijlst L, Chamuleau R, Hoekstra R, Wanders R, Silva M. Advances in methods for characterization of hepatic urea cycle enzymatic activity in HepaRG cells using UPLC-MS/MS. Analytical Biochemistry 2017;535:47-55. [DOI: 10.1016/j.ab.2017.07.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
13 Meng FY, Liu L, Yang FH, Li CY, Liu J, Zhou P. Reversible immortalization of human hepatocytes mediated by retroviral transfer and site-specific recombination. World J Gastroenterol 2014; 20(36): 13119-13126 [PMID: 25278705 DOI: 10.3748/wjg.v20.i36.13119] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
14 Ashraf MN, Asghar MW, Rong Y, Doschak MR, Kiang TKL. Advanced In Vitro HepaRG Culture Systems for Xenobiotic Metabolism and Toxicity Characterization. Eur J Drug Metab Pharmacokinet 2019;44:437-58. [DOI: 10.1007/s13318-018-0533-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
15 Hiller T, Berg J, Elomaa L, Röhrs V, Ullah I, Schaar K, Dietrich AC, Al-Zeer MA, Kurtz A, Hocke AC, Hippenstiel S, Fechner H, Weinhart M, Kurreck J. Generation of a 3D Liver Model Comprising Human Extracellular Matrix in an Alginate/Gelatin-Based Bioink by Extrusion Bioprinting for Infection and Transduction Studies. Int J Mol Sci 2018;19:E3129. [PMID: 30321994 DOI: 10.3390/ijms19103129] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 12.0] [Reference Citation Analysis]
16 Rebelo SP, Costa R, Estrada M, Shevchenko V, Brito C, Alves PM. HepaRG microencapsulated spheroids in DMSO-free culture: novel culturing approaches for enhanced xenobiotic and biosynthetic metabolism. Arch Toxicol 2015;89:1347-58. [PMID: 25107451 DOI: 10.1007/s00204-014-1320-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
17 Costantini M, Guzowski J, Żuk PJ, Mozetic P, De Panfilis S, Jaroszewicz J, Heljak M, Massimi M, Pierron M, Trombetta M, Dentini M, Święszkowski W, Rainer A, Garstecki P, Barbetta A. Electric Field Assisted Microfluidic Platform for Generation of Tailorable Porous Microbeads as Cell Carriers for Tissue Engineering. Adv Funct Mater 2018;28:1800874. [DOI: 10.1002/adfm.201800874] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
18 Malinen MM, Ito K, Kang HE, Honkakoski P, Brouwer KLR. Protein expression and function of organic anion transporters in short-term and long-term cultures of Huh7 human hepatoma cells. Eur J Pharm Sci 2019;130:186-95. [PMID: 30685239 DOI: 10.1016/j.ejps.2019.01.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
19 van Wenum M, Adam AA, Hakvoort TB, Hendriks EJ, Shevchenko V, van Gulik TM, Chamuleau RA, Hoekstra R. Selecting Cells for Bioartificial Liver Devices and the Importance of a 3D Culture Environment: A Functional Comparison between the HepaRG and C3A Cell Lines. Int J Biol Sci 2016;12:964-78. [PMID: 27489500 DOI: 10.7150/ijbs.15165] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
20 Anthérieu S, Chesné C, Li R, Guguen-Guillouzo C, Guillouzo A. Optimization of the HepaRG cell model for drug metabolism and toxicity studies. Toxicol In Vitro 2012;26:1278-85. [PMID: 22643240 DOI: 10.1016/j.tiv.2012.05.008] [Cited by in Crossref: 105] [Cited by in F6Publishing: 103] [Article Influence: 10.5] [Reference Citation Analysis]
21 Lee HJ, Son MJ, Ahn J, Oh SJ, Lee M, Kim A, Jeung YJ, Kim HG, Won M, Lim JH, Kim NS, Jung CR, Chung KS. Elasticity-based development of functionally enhanced multicellular 3D liver encapsulated in hybrid hydrogel. Acta Biomater 2017;64:67-79. [PMID: 28966094 DOI: 10.1016/j.actbio.2017.09.041] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
22 Adam AAA, Jongejan A, Moerland PD, van der Mark VA, Oude Elferink RP, Chamuleau RAFM, Hoekstra R. Genome-wide expression profiling reveals increased stability and mitochondrial energy metabolism of the human liver cell line HepaRG-CAR. Cytotechnology 2020;72:377-95. [PMID: 32130581 DOI: 10.1007/s10616-020-00384-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 van Wenum M, Treskes P, Tang CY, Coppens EJ, Jansen K, Hendriks EJ, Camus S, van Gulik TM, Chamuleau RAFM, Hoekstra R. Scaling-up of a HepaRG progenitor cell based bioartificial liver: optimization for clinical application and transport. Biofabrication 2017;9:035001. [PMID: 28664876 DOI: 10.1088/1758-5090/aa7657] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
24 Tascher G, Burban A, Camus S, Plumel M, Chanon S, Le Guevel R, Shevchenko V, Van Dorsselaer A, Lefai E, Guguen-Guillouzo C, Bertile F. In-Depth Proteome Analysis Highlights HepaRG Cells as a Versatile Cell System Surrogate for Primary Human Hepatocytes. Cells 2019;8:E192. [PMID: 30795634 DOI: 10.3390/cells8020192] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
25 Ngo LP, Owiti NA, Swartz C, Winters J, Su Y, Ge J, Xiong A, Han J, Recio L, Samson LD, Engelward BP. Sensitive CometChip assay for screening potentially carcinogenic DNA adducts by trapping DNA repair intermediates. Nucleic Acids Res 2020;48:e13. [PMID: 31822921 DOI: 10.1093/nar/gkz1077] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
26 van Wenum M, Adam AAA, van der Mark VA, Chang JC, Wildenberg ME, Hendriks EJ, Jongejan A, Moerland PD, van Gulik TM, Oude Elferink RP, Chamuleau RAFM, Hoekstra R. Oxygen drives hepatocyte differentiation and phenotype stability in liver cell lines. J Cell Commun Signal 2018;12:575-88. [PMID: 29399736 DOI: 10.1007/s12079-018-0456-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
27 Boul M, Benzoubir N, Messina A, Ghasemi R, Mosbah IB, Duclos-Vallée JC, Dubart-Kupperschmitt A, Le Pioufle B. A versatile microfluidic tool for the 3D culture of HepaRG cells seeded at various stages of differentiation. Sci Rep 2021;11:14075. [PMID: 34234159 DOI: 10.1038/s41598-021-92011-7] [Reference Citation Analysis]
28 Hoekstra R, Nibourg GA, van der Hoeven TV, Plomer G, Seppen J, Ackermans MT, Camus S, Kulik W, van Gulik TM, Elferink RP. Phase 1 and phase 2 drug metabolism and bile acid production of HepaRG cells in a bioartificial liver in absence of dimethyl sulfoxide. Drug Metab Dispos. 2013;41:562-567. [PMID: 23238784 DOI: 10.1124/dmd.112.049098] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
29 Andersson TB, Kanebratt KP, Kenna JG. The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human. Expert Opin Drug Metab Toxicol 2012;8:909-20. [PMID: 22568886 DOI: 10.1517/17425255.2012.685159] [Cited by in Crossref: 140] [Cited by in F6Publishing: 130] [Article Influence: 14.0] [Reference Citation Analysis]
30 Guillouzo A, Guguen-guillouzo C. HepaRG Cells as a Model for Hepatotoxicity Studies. Stem Cells in Birth Defects Research and Developmental Toxicology. Hoboken: John Wiley & Sons, Inc; 2018. pp. 309-39. [DOI: 10.1002/9781119283249.ch12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
31 Mayati A, Moreau A, Le Vée M, Bruyère A, Jouan E, Denizot C, Parmentier Y, Fardel O. Functional polarization of human hepatoma HepaRG cells in response to forskolin. Sci Rep 2018;8:16115. [PMID: 30382126 DOI: 10.1038/s41598-018-34421-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
32 Selden C, Bundy J, Erro E, Puschmann E, Miller M, Kahn D, Hodgson H, Fuller B, Gonzalez-Molina J, Le Lay A, Gibbons S, Chalmers S, Modi S, Thomas A, Kilbride P, Isaacs A, Ginsburg R, Ilsley H, Thomson D, Chinnery G, Mankahla N, Loo L, Spearman CW. A clinical-scale BioArtificial Liver, developed for GMP, improved clinical parameters of liver function in porcine liver failure. Sci Rep. 2017;7:14518. [PMID: 29109530 DOI: 10.1038/s41598-017-15021-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
33 Alépée N, Bahinski A, Daneshian M, De Wever B, Fritsche E, Goldberg A, Hansmann J, Hartung T, Haycock J, Hogberg H, Hoelting L, Kelm JM, Kadereit S, McVey E, Landsiedel R, Leist M, Lübberstedt M, Noor F, Pellevoisin C, Petersohn D, Pfannenbecker U, Reisinger K, Ramirez T, Rothen-Rutishauser B, Schäfer-Korting M, Zeilinger K, Zurich MG. State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology. ALTEX 2014;31:441-77. [PMID: 25027500 DOI: 10.14573/altex.1406111] [Cited by in Crossref: 12] [Cited by in F6Publishing: 62] [Article Influence: 1.5] [Reference Citation Analysis]
34 van der Mark VA, Adam AAA, Chang JC, Oude Elferink RP, Chamuleau RAFM, Hoekstra R. Overexpression of the constitutive androstane receptor and shaken 3D-culturing increase biotransformation and oxidative phosphorylation and sensitivity to mitochondrial amiodarone toxicity of HepaRG cells. Toxicol Appl Pharmacol 2020;399:115055. [PMID: 32428594 DOI: 10.1016/j.taap.2020.115055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Adam AAA, van Wenum M, van der Mark VA, Jongejan A, Moerland PD, Houtkooper RH, Wanders RJA, Oude Elferink RP, Chamuleau RAFM, Hoekstra R. AMC-Bio-Artificial Liver culturing enhances mitochondrial biogenesis in human liver cell lines: The role of oxygen, medium perfusion and 3D configuration. Mitochondrion 2018;39:30-42. [PMID: 28844938 DOI: 10.1016/j.mito.2017.08.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
36 Kitano H, Nagae Y, Kawabe Y, Ito A, Kamihira M. Development of a genetically modified hepatoma cell line with heat-inducible high liver function. Cytotechnology 2021;73:353-62. [PMID: 34149171 DOI: 10.1007/s10616-021-00457-4] [Reference Citation Analysis]
37 Klein S, Mueller D, Schevchenko V, Noor F. Long-term maintenance of HepaRG cells in serum-free conditions and application in a repeated dose study: Serum-free HepaRG culture for long-term toxicity assessment. J Appl Toxicol 2014;34:1078-86. [DOI: 10.1002/jat.2929] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
38 Moradi E, Jalili-Firoozinezhad S, Solati-Hashjin M. Microfluidic organ-on-a-chip models of human liver tissue. Acta Biomater 2020;116:67-83. [PMID: 32890749 DOI: 10.1016/j.actbio.2020.08.041] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
39 Mueller D, Krämer L, Hoffmann E, Klein S, Noor F. 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies. Toxicology in Vitro 2014;28:104-12. [DOI: 10.1016/j.tiv.2013.06.024] [Cited by in Crossref: 97] [Cited by in F6Publishing: 95] [Article Influence: 12.1] [Reference Citation Analysis]
40 Mueller D, Heinzle E. Stable isotope-assisted metabolomics to detect metabolic flux changes in mammalian cell cultures. Curr Opin Biotechnol 2013;24:54-9. [PMID: 23142545 DOI: 10.1016/j.copbio.2012.10.015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
41 Desaulniers D, Cummings-Lorbetskie C, Leingartner K, Xiao GH, Zhou G, Parfett C. Effects of vanadium (sodium metavanadate) and aflatoxin-B1 on cytochrome p450 activities, DNA damage and DNA methylation in human liver cell lines. Toxicol In Vitro 2021;70:105036. [PMID: 33164849 DOI: 10.1016/j.tiv.2020.105036] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Yamamoto H, Tonello JM, Sambuichi T, Kawabe Y, Ito A, Kamihira M. Characterization of genetically engineered mouse hepatoma cells with inducible liver functions by overexpression of liver-enriched transcription factors. J Biosci Bioeng 2018;125:131-9. [PMID: 28847578 DOI: 10.1016/j.jbiosc.2017.07.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
43 Blidisel A, Marcovici I, Coricovac D, Hut F, Dehelean CA, Cretu OM. Experimental Models of Hepatocellular Carcinoma-A Preclinical Perspective. Cancers (Basel) 2021;13:3651. [PMID: 34359553 DOI: 10.3390/cancers13153651] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Atzrodt J, Derdau V, Kerr WJ, Reid M. Deuterium- and Tritium-Labelled Compounds: Applications in the Life Sciences. Angew Chem Int Ed Engl 2018;57:1758-84. [PMID: 28815899 DOI: 10.1002/anie.201704146] [Cited by in Crossref: 220] [Cited by in F6Publishing: 138] [Article Influence: 55.0] [Reference Citation Analysis]
45 Ahn J, Lee HJ, Oh SJ, Kim W, Mun SJ, Lee JH, Jung CR, Cho HS, Kim DS, Son MJ, Chung KS. Developing scalable cultivation systems of hepatic spheroids for drug metabolism via genomic and functional analyses. Biotechnol Bioeng 2019;116:1496-508. [PMID: 30737956 DOI: 10.1002/bit.26954] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
46 Chen Z, Tang N, Wang X, Chen Y. The activity of the carbamoyl phosphate synthase 1 promoter in human liver-derived cells is dependent on hepatocyte nuclear factor 3-beta. J Cell Mol Med. 2017;21:2036-2045. [PMID: 28272778 DOI: 10.1111/jcmm.13123] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
47 Lin TY, Ki CS, Lin CC. Manipulating hepatocellular carcinoma cell fate in orthogonally cross-linked hydrogels. Biomaterials 2014;35:6898-906. [PMID: 24857292 DOI: 10.1016/j.biomaterials.2014.04.118] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
48 Pan X, Li L. Advances in cell sources of hepatocytes for bioartificial liver. Hepatobiliary & Pancreatic Diseases International 2012;11:594-605. [DOI: 10.1016/s1499-3872(12)60230-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
49 Alépée N, Bahinski A, Daneshian M, De Wever B, Fritsche E, Goldberg A, Hansmann J, Hartung T, Haycock J, Hogberg H, Hoelting L, Kelm JM, Kadereit S, McVey E, Landsiedel R, Leist M, Lübberstedt M, Noor F, Pellevoisin C, Petersohn D, Pfannenbecker U, Reisinger K, Ramirez T, Rothen-Rutishauser B, Schäfer-Korting M, Zeilinger K, Zurich MG. State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology. ALTEX 2014;31:441-77. [PMID: 25027500 DOI: 10.14573/altex.1406111] [Cited by in Crossref: 98] [Cited by in F6Publishing: 46] [Article Influence: 12.3] [Reference Citation Analysis]
50 Adam AAA, van der Mark VA, Donkers JM, Wildenberg ME, Oude Elferink RPJ, Chamuleau RAFM, Hoekstra R. A practice-changing culture method relying on shaking substantially increases mitochondrial energy metabolism and functionality of human liver cell lines. PLoS One 2018;13:e0193664. [PMID: 29672606 DOI: 10.1371/journal.pone.0193664] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
51 Chen K, Pernelle K, Tsai Y, Wu Y, Hsieh J, Liao K, Guguen-guillouzo C, Wang H. Liver X receptor α (LXRα/NR1H3) regulates differentiation of hepatocyte-like cells via reciprocal regulation of HNF4α. Journal of Hepatology 2014;61:1276-86. [DOI: 10.1016/j.jhep.2014.07.025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
52 Nibourg GA, Chamuleau RA, van Gulik TM, Hoekstra R. Proliferative human cell sources applied as biocomponent in bioartificial livers: a review. Expert Opinion on Biological Therapy 2012;12:905-21. [DOI: 10.1517/14712598.2012.685714] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
53 Nicolas C, Wang Y, Luebke-Wheeler J, Nyberg SL. Stem Cell Therapies for Treatment of Liver Disease. Biomedicines 2016;4:E2. [PMID: 28536370 DOI: 10.3390/biomedicines4010002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
54 Richter M, Fairhall EA, Hoffmann SA, Tröbs S, Knöspel F, Probert PME, Oakley F, Stroux A, Wright MC, Zeilinger K. Pancreatic progenitor-derived hepatocytes are viable and functional in a 3D high density bioreactor culture system. Toxicol Res (Camb) 2016;5:278-90. [PMID: 30090344 DOI: 10.1039/c5tx00187k] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
55 Leite SB, Wilk-zasadna I, Zaldivar JM, Airola E, Reis-fernandes MA, Mennecozzi M, Guguen-guillouzo C, Chesne C, Guillou C, Alves PM, Coecke S. Three-Dimensional HepaRG Model As An Attractive Tool for Toxicity Testing. Toxicological Sciences 2012;130:106-16. [DOI: 10.1093/toxsci/kfs232] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 6.4] [Reference Citation Analysis]
56 Nibourg GAA, Hoekstra R, van der Hoeven TV, Ackermans MT, Hakvoort TBM, van Gulik TM, Chamuleau RAFM. Effects of acute-liver-failure-plasma exposure on hepatic functionality of HepaRG-AMC-Bioartificial Liver. Liver Int 2013;33:516-24. [DOI: 10.1111/liv.12090] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
57 Gerbal-Chaloin S, Funakoshi N, Caillaud A, Gondeau C, Champon B, Si-Tayeb K. Human induced pluripotent stem cells in hepatology: beyond the proof of concept. Am J Pathol. 2014;184:332-347. [PMID: 24269594 DOI: 10.1016/j.ajpath.2013.09.026] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
58 Ong LJY, Chong LH, Jin L, Singh PK, Lee PS, Yu H, Ananthanarayanan A, Leo HL, Toh YC. A pump-free microfluidic 3D perfusion platform for the efficient differentiation of human hepatocyte-like cells. Biotechnol Bioeng 2017;114:2360-70. [PMID: 28542705 DOI: 10.1002/bit.26341] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
59 Nibourg GA, Chamuleau RA, van der Hoeven TV, Maas MA, Ruiter AF, Lamers WH, Oude Elferink RP, van Gulik TM, Hoekstra R. Liver progenitor cell line HepaRG differentiated in a bioartificial liver effectively supplies liver support to rats with acute liver failure. PLoS One 2012;7:e38778. [PMID: 22719943 DOI: 10.1371/journal.pone.0038778] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
60 Hoekstra R, Nibourg GA, Van der Hoeven TV, Ackermans MT, Hakvoort TB, Van Gulik TM, Oude Elferink RP, Chamuleau RA. The Effect of Rat Acute-Liver-Failure Plasma on HepaRG Cells. Int J Artif Organs 2012;35:1006-14. [DOI: 10.1177/039139881203501106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
61 Wang Z, Luo X, Anene-Nzelu C, Yu Y, Hong X, Singh NH, Xia L, Liu S, Yu H. HepaRG culture in tethered spheroids as an in vitro three-dimensional model for drug safety screening. J Appl Toxicol 2015;35:909-17. [PMID: 25512232 DOI: 10.1002/jat.3090] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
62 Swart M, Dandara C. MicroRNA Mediated Changes in Drug Metabolism and Target Gene Expression by Efavirenz and Rifampicin In Vitro: Clinical Implications. OMICS 2019;23:496-507. [PMID: 31526233 DOI: 10.1089/omi.2019.0122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
63 Legallais C, Kim D, Mihaila SM, Mihajlovic M, Figliuzzi M, Bonandrini B, Salerno S, Yousef Yengej FA, Rookmaaker MB, Sanchez Romero N, Sainz-Arnal P, Pereira U, Pasqua M, Gerritsen KGF, Verhaar MC, Remuzzi A, Baptista PM, De Bartolo L, Masereeuw R, Stamatialis D. Bioengineering Organs for Blood Detoxification. Adv Healthc Mater 2018;7:e1800430. [PMID: 30230709 DOI: 10.1002/adhm.201800430] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
64 Nibourg GA, Boer JD, van der Hoeven TV, Ackermans MT, van Gulik TM, Chamuleau RA, Hoekstra R. Perfusion flow rate substantially contributes to the performance of the HepaRG-AMC-bioartificial liver. Biotechnol Bioeng 2012;109:3182-8. [PMID: 22729831 DOI: 10.1002/bit.24586] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
65 Yan Q, Zhao XM, Deng LJ, Fang YX, Lin JJ, Li AM. Human hepatocellular adenoma as a promising cell source for bioartificial liver systems. Exp Ther Med 2019;18:1357-65. [PMID: 31316625 DOI: 10.3892/etm.2019.7673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]